November 17, 2023

Bedrocan highlights SyqeAir’s TGA Approval in Australia

An article by Bedrocan about Syqe® receiving the Therapeutic Goods Administration (TGA) approval for the SyqeAir inhaler in Australia. This significant regulatory milestone is a step forward in the global expansion of our treatment.

Great Love Can Conquer The Strongest Pain – Nelly & Guy

07/02/2022

A heartwarming testimonial movie about true love, starring our patient, Nelly, and her spouse, Guy. A story of love and partnership in the shadow of chronic pain.

Chronic Patients Hit ‘Sweet Spot’ With Cannabis Inhaler

23/04/2023

Israeli startup Syqe® says it’s solved the problem of unpredictable and inconsistent medical cannabis treatment with the SyqeAir Inhaler and Cartridges that deliver the same dose of cannabis every time.

Rehabilitation Nation: Israeli Innovation On The Road To Healing

02/10/2024

NoCamels News: Syqe®’s online questionnaire for self-identification of early symptoms that characterize PTSD to provide the public with an initial identification tool to promote awareness and seek immediate treatment.

Medical Cannabis

SyqeAir Inhaler

Useful Information

Media

Contact Syqe®

Phone. +972-3-376-7338
Email. info@syqemed.com
Syqe® Israel. syqe.co.il

Show Us Some Love

The site and the content therein are provided for general knowledge only and do not constitute advertising and/or medical, pharmacological, or professional advice, diagnosis, treatment, or other healthcare services that in any way generate a doctor-patient relationship and/or recommendation for treatment or products in general, and for medical cannabis products and/or SyqeAir inhaler in particular. You should make all medical or health-related decisions on the basis of professional advice from a licensed physician or qualified healthcare professional who is fully aware of your individual circumstances. For any questions regarding products, including medical cannabis products and/or the SyqeAir inhaler, please consult your attending physician and/or the pharmacist at the dispensing pharmacy. The use and reliance on all content appearing on this site are at your sole responsibility, and Syqe® will not be responsible for any decision or action taken by you as a result of relying on this site.

Day: November 17, 2023

Bedrocan highlights SyqeAir’s TGA Approval in Australia

Related Posts

Great Love Can Conquer The Strongest Pain – Nelly & Guy

Chronic Patients Hit ‘Sweet Spot’ With Cannabis Inhaler

Rehabilitation Nation: Israeli Innovation On The Road To Healing